Wag! Reports Record Second Quarter 2023 Results
Highest Service Revenue Quarter To Date
First Quarter of Adjusted EBITDA Profitability
Raises Previously Announced 2023 Full Year Adjusted EBITDA Guidance
Second Quarter 2023 Highlights:
-
Revenue increased 55% to
$19.8 million , compared to$12.8 million in the second quarter of 2022, a quarterly revenue milestone – comprised of$6.2 million of Services revenue,$12.0 million of Wellness revenue, and$1.6 million of Pet Food & Treats revenue.
-
Net loss was
$3.9 million , compared to$1.1 million in the second quarter of 2022, primarily due to year-over-year increases in interest expense and stock-based compensation.
-
Adjusted EBITDA improved to positive
$0.1 million , compared to an Adjusted EBITDA loss of$0.9 million in the second quarter of 2022.
"We're thrilled to share our first Adjusted EBITDA positive quarter as a public company, and for the fifth consecutive quarter we are revising our Adjusted EBITDA guidance upward," said
“We are continuing to make long-term investments across the business in order to balance growth and profitability in 2023 and beyond,” concluded Smallwood.
Recent Business Highlights:
- Reached a total of 549,000 Platform Participants in Q2 2023, an increase of 42% from 387,000 in Q2 2022.
-
First Adjusted EBITDA Positive Quarter in Company History – our deliberate 10:1 LTV:CAC ratio, disciplined expense management, and AI automation of back-office tasks and vendors drove the first profitable quarter in company history.
-
Record Services Quarter – achieved quarterly revenue milestone for Services, setting an all-time revenue record despite the slow return-to-office trend per the Kastle Back to Work Barometer.
- Delighted Pet Parents through Paw Protect – launched Paw Protect into Wellness marketplace and delighted thousands of Pet Parents through a best-in-class, innovative pet insurance product with a record 94 NPS.
Guidance
"As a result of our strong second quarter and year to date results, we are again increasing our guidance for 2023,” said
For the full-year of 2023, we now expect:
-
Revenue in the range of
$80 million to$84 million , consistent with our prior forecast.
-
Adjusted EBITDA1 in the range of
$0 million to$2 million , a$1 million improvement versus our prior forecast at the high end of the range.
For the third quarter 2023, we expect:
-
Revenue in the range of
$19 million to$20 million , a year-over-year increase of 27% at the midpoint of the range.
-
Adjusted EBITDA1 in the range of
$0 million to$1 million , a 208% improvement year-over-year at the midpoint of the range.
Our intense focus on profitability and operational efficiencies in 2023 positions us well for profitable growth in 2024 and beyond.
Our financial guidance includes the following outlook:
- Severe weather affects Services demand and holidays drive incremental overnight vs. daytime service demand. Going forward, we expect a skew to Overnight and Daytime services depending on summer and holidays. Pet adoption during the holidays also affects pet insurance penetration and demand for wellness plans.
- We anticipate that continued growth in the pet industry, driven by factors such as rising pet ownership, pet insurance penetration, and increasing demand for premium pet products and services, will have a positive impact on our financial performance in 2023, including on our entrance to Pet Food & Treats.
- General trends related to state of the economy, interest rates, and consumer confidence. We have factored in potential risks and opportunities related to these macroeconomic factors in order to accurately forecast our financial performance.
- We recognize that there may be potential risks to our financial performance in 2023, such as disruptions to global supply chains, changes in consumer behavior due to unexpected events such as a delayed or imbalanced return-to-office, digital and performance marketing trends, the potential impact of AI, and our ability to expand through partnerships.
1 Information reconciling forward-looking adjusted EBITDA to the comparable GAAP financial measures is unavailable to the company without unreasonable effort, as discussed in our Non-GAAP Financial Measures and Other Operating Metrics section below.
Wag’s Second Quarter Results Conference Call
Wag! will host a conference call and live webcast today,
Wag! also provides announcements regarding financial performance and other matters, including
About Wag! – Wag.co
Non-GAAP Financial Measures and Other Operating Metrics
Adjusted EBITDA is a non-GAAP financial measure defined as net income (loss) adjusted for interest expense, depreciation and amortization, share-based compensation, income taxes, as well as other items to be consistent with definitions typically used by lenders, including transaction costs. Additionally, we exclude the impact of certain non-recurring items which are not indicative of our operating performance as well as other transaction specific costs that do not represent an ongoing operating expense of the business, including but not limited to, business combination transaction and integration costs and PPP loan forgiveness. Adjusted EBITDA margin is calculated by dividing Adjusted EBITDA by revenue. Adjusted EBITDA and Adjusted EBITDA margin provide a basis for comparison of our business operations between current, past, and future periods by excluding items from net income (loss) that we do not believe are indicative of our core operating performance.
Platform Participant is defined as a Pet Parent or Pet Caregiver who transacted on the Wag! platform for a service in the quarter. Services include dog walking, sitting, boarding, drop-ins, training, premium telehealth services, wellness plans, and pet insurance plan comparison.
Information reconciling forward-looking adjusted EBITDA to GAAP financial measures is unavailable to the company without unreasonable effort. The company is not able to provide reconciliations of adjusted EBITDA to GAAP financial measures because certain items required for such reconciliations are outside of the company’s control and/or cannot be reasonably predicted, such as the provision for income taxes. Preparation of such reconciliations would require a forward-looking balance sheet, statement of income and statement of cash flow, prepared in accordance with GAAP, and such forward-looking financial statements are unavailable to the company without unreasonable effort. The company provides a range for its adjusted EBITDA forecast that it believes will be achieved, however it cannot accurately predict all the components of the adjusted EBITDA calculation. The company provides an adjusted EBITDA forecast because it believes that adjusted EBITDA, when viewed with the company’s results under GAAP, provides useful information for the reasons noted above. However, adjusted EBITDA is not a measure of financial performance or liquidity under GAAP and, accordingly, should not be considered as an alternative to net income or cash flow from operating activities as an indicator of operating performance or liquidity.
Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including the words “anticipate,” “expect,” “suggests,” “plan,” “believe,” “intend,” “estimates,” “targets,” “projects,” “should,” “could,” “would,” “may,” “will,” “forecast” and other similar expressions are intended to identify forward-looking statements. These statements include those related to the Company’s ability to further develop and advance its pet service offerings and achieve scale; ability to attract and retain personnel; market opportunity, anticipated growth, and future financial performance, including management’s financial outlook for the future. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: management’s financial outlook for the future; market adoption of the Company’s pet service offerings and solutions; failure to realize the financial benefits of acquisitions; the ability of the Company to protect its intellectual property; changes in the competitive industries in which the Company operates; changes in laws and regulations affecting the Company’s business; the Company’s ability to implement its business plans, forecasts and other expectations, and identify and realize additional partnerships and opportunities; and the risk of downturns in the market and the technology industry. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Company’s filings, including the Annual Report on Form 10-K for the year ended
Condensed Consolidated Balance Sheets (unaudited) |
||||||
|
|
|
|
|
||
|
|
(in thousands, except par value amounts) |
||||
ASSETS |
||||||
Current assets: |
|
|
|
|
||
Cash and cash equivalents |
|
$ |
24,792 |
|
$ |
38,966 |
Accounts receivable, net |
|
|
7,762 |
|
|
5,872 |
Prepaid expenses and other current assets |
|
|
1,984 |
|
|
2,585 |
Total current assets |
|
|
34,538 |
|
|
47,423 |
Property and equipment, net |
|
|
89 |
|
|
88 |
Operating lease right-of-use assets |
|
|
1,210 |
|
|
695 |
Intangible assets, net |
|
|
7,814 |
|
|
2,590 |
|
|
|
5,096 |
|
|
1,451 |
Other assets |
|
|
2,092 |
|
|
64 |
Total assets |
|
$ |
50,839 |
|
$ |
52,311 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||
Current liabilities: |
|
|
|
|
||
Accounts payable |
|
$ |
9,672 |
|
$ |
7,174 |
Accrued expenses and other current liabilities |
|
|
4,150 |
|
|
4,765 |
Deferred revenue |
|
|
2,627 |
|
|
2,232 |
Deferred purchase consideration – current portion |
|
|
750 |
|
|
750 |
Operating lease liabilities |
|
|
253 |
|
|
306 |
Notes payable – current portion |
|
|
1,427 |
|
|
1,264 |
Total current liabilities |
|
|
18,879 |
|
|
16,491 |
Operating lease liabilities – non-current portion |
|
|
981 |
|
|
435 |
Notes payable – non-current portion, net of debt discount and warrant allocation of |
|
|
25,570 |
|
|
24,970 |
Deferred purchase consideration – non-current portion |
|
|
147 |
|
|
493 |
Other non-current liabilities |
|
|
218 |
|
|
— |
Total liabilities |
|
|
45,795 |
|
|
42,389 |
Commitments and contingencies |
|
|
|
|
||
Stockholders’ equity |
|
|
|
|
||
Common stock, |
|
|
4 |
|
|
4 |
Additional paid-in capital |
|
|
161,113 |
|
|
158,335 |
Accumulated deficit |
|
|
(156,073) |
|
|
(148,417) |
Total stockholders’ equity |
|
|
5,044 |
|
|
9,922 |
Total liabilities and stockholders’ equity |
|
$ |
50,839 |
|
$ |
52,311 |
Condensed Consolidated Statements of Operations (unaudited) |
||||||||||||
|
|
Three Months Ended |
|
Six Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
||||
|
|
(in thousands, except per share amounts) |
||||||||||
Revenues |
|
$ |
19,820 |
|
$ |
12,784 |
|
$ |
40,443 |
|
$ |
22,450 |
Costs and expenses: |
|
|
|
|
|
|
|
|
||||
Cost of revenues (exclusive of depreciation and amortization shown separately below) |
|
|
1,243 |
|
|
1,200 |
|
|
2,269 |
|
|
2,006 |
Platform operations and support |
|
|
3,492 |
|
|
2,817 |
|
|
6,662 |
|
|
5,394 |
Sales and marketing |
|
|
10,758 |
|
|
7,284 |
|
|
24,033 |
|
|
13,366 |
Royalty |
|
|
1,791 |
|
|
— |
|
|
1,791 |
|
|
— |
General and administrative |
|
|
4,821 |
|
|
2,398 |
|
|
9,805 |
|
|
4,765 |
Depreciation and amortization |
|
|
375 |
|
|
145 |
|
|
756 |
|
|
297 |
Total costs and expenses |
|
|
22,480 |
|
|
13,844 |
|
|
45,316 |
|
|
25,828 |
Other expense, net |
|
|
65 |
|
|
— |
|
|
9 |
|
|
— |
Interest expense, net |
|
|
1,659 |
|
|
17 |
|
|
3,289 |
|
|
49 |
Loss before income taxes and equity in net earnings of equity method investments |
|
|
(4,384) |
|
|
(1,077) |
|
|
(8,171) |
|
|
(3,427) |
Income taxes |
|
|
38 |
|
|
13 |
|
|
38 |
|
|
13 |
Equity in net earnings of equity method investments |
|
|
553 |
|
|
— |
|
|
553 |
|
|
— |
Net loss |
|
$ |
(3,869) |
|
$ |
(1,090) |
|
$ |
(7,656) |
|
$ |
(3,440) |
Loss per share, basic and diluted |
|
$ |
(0.10) |
|
$ |
(0.18) |
|
$ |
(0.20) |
|
$ |
(0.56) |
Weighted-average common shares outstanding used in computing loss per share, basic and diluted |
|
|
38,109 |
|
|
6,129 |
|
|
37,590 |
|
|
6,125 |
Condensed Consolidated Statements of Cash Flows (unaudited) |
||||||
|
|
Six Months Ended |
||||
|
|
|
|
|
||
|
|
(in thousands) |
||||
Cash flow from operating activities: |
|
|
|
|
||
Net loss |
|
$ |
(7,656) |
|
$ |
(3,440) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
||
Stock-based compensation |
|
|
2,463 |
|
|
94 |
Amortization of debt discount on debt financing |
|
|
1,314 |
|
|
— |
Depreciation and amortization |
|
|
756 |
|
|
297 |
Non-cash interest expense – deferred purchase consideration |
|
|
36 |
|
|
58 |
Equity in net earnings of equity method investments |
|
|
(553) |
|
|
— |
Changes in operating assets and liabilities, net of effect of acquired business: |
|
|
|
|
||
Accounts receivable |
|
|
(1,850) |
|
|
(1,854) |
Prepaid expenses and other current assets |
|
|
1,049 |
|
|
(59) |
Operating lease right-of-use assets and liabilities |
|
|
(8) |
|
|
14 |
Other assets |
|
|
(5) |
|
|
— |
Accounts payable |
|
|
2,241 |
|
|
1,060 |
Accrued expenses and other current liabilities |
|
|
(700) |
|
|
(536) |
Deferred revenue |
|
|
368 |
|
|
220 |
Other non-current liabilities |
|
|
218 |
|
|
— |
Net cash used in operating activities |
|
|
(2,327) |
|
|
(4,146) |
Cash flows from investing activities: |
|
|
|
|
||
Purchases of short-term investments |
|
|
— |
|
|
(10,092) |
Proceeds from sale and maturity of short-term investments |
|
|
— |
|
|
5,901 |
Payment of deferred purchase consideration |
|
|
(382) |
|
|
(375) |
Cash paid for acquisitions, net of cash acquired |
|
|
(9,503) |
|
|
— |
Cash paid for equity method investment |
|
|
(1,470) |
|
|
— |
Purchase of property and equipment |
|
|
(31) |
|
|
(14) |
Net cash used in investing activities |
|
|
(11,386) |
|
|
(4,580) |
Cash flows from financing activities: |
|
|
|
|
||
Proceeds from exercises of stock options |
|
|
90 |
|
|
— |
Payments on PPP loan and Blue Torch Financing Agreement |
|
|
(551) |
|
|
(220) |
Proceeds from issuance of Series P preferred stock, net of issuance costs |
|
|
— |
|
|
10,925 |
Payment of offering costs |
|
|
— |
|
|
(2,169) |
Net cash provided by (used in) financing activities |
|
|
(461) |
|
|
8,536 |
Net change in cash, cash equivalents, and restricted cash |
|
|
(14,174) |
|
|
(190) |
Cash, cash equivalents, and restricted cash, beginning of period |
|
|
38,966 |
|
|
2,628 |
Cash, cash equivalents, and restricted cash, end of period |
|
$ |
24,792 |
|
$ |
2,438 |
Adjusted EBITDA Reconciliation (unaudited) |
||||||||||||
|
|
Three Months Ended |
|
Six Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
||||
|
|
(in thousands, except percentages) |
||||||||||
Net loss |
|
$ |
(3,869) |
|
$ |
(1,090) |
|
$ |
(7,656) |
|
$ |
(3,440) |
Interest expense, net |
|
|
1,659 |
|
|
17 |
|
|
3,289 |
|
|
49 |
Income taxes |
|
|
38 |
|
|
13 |
|
|
38 |
|
|
13 |
Depreciation and amortization |
|
|
375 |
|
|
145 |
|
|
756 |
|
|
297 |
Stock-based compensation |
|
|
1,121 |
|
|
40 |
|
|
2,463 |
|
|
94 |
Integration and transaction costs associated with acquired business |
|
|
152 |
|
|
— |
|
|
189 |
|
|
— |
Severance costs |
|
|
131 |
|
|
— |
|
|
131 |
|
|
— |
Legal settlement |
|
|
500 |
|
|
— |
|
|
500 |
|
|
— |
Adjusted EBITDA (loss) |
|
$ |
107 |
|
$ |
(875) |
|
$ |
(290) |
|
$ |
(2,987) |
Revenues |
|
$ |
19,820 |
|
$ |
12,784 |
|
$ |
40,443 |
|
$ |
22,450 |
Adjusted EBITDA (loss) margin |
|
|
0.5 % |
|
|
(6.8) % |
|
|
(0.7) % |
|
|
(13.3) % |
Non-GAAP Measures (unaudited) |
||||||||||||
|
|
Three Months Ended |
|
Six Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
||||
|
|
(in thousands, except percentages) |
||||||||||
|
|
|
|
|
|
|
|
|
||||
Revenues |
|
$ |
19,820 |
|
$ |
12,784 |
|
$ |
40,443 |
|
$ |
22,450 |
Net loss |
|
$ |
(3,869) |
|
$ |
(1,090) |
|
$ |
(7,656) |
|
$ |
(3,440) |
Net loss margin |
|
|
(19.5) % |
|
|
(8.5) % |
|
|
(18.9) % |
|
|
(15.3) % |
Net cash provided by (used in) operating activities |
|
$ |
1,253 |
|
$ |
(1,901) |
|
$ |
(2,327) |
|
$ |
(4,146) |
Non-GAAP measures: |
|
|
|
|
|
|
|
|
||||
Adjusted EBITDA (loss) |
|
$ |
107 |
|
$ |
(875) |
|
$ |
(290) |
|
$ |
(2,987) |
Adjusted EBITDA (loss) margin |
|
|
0.5 % |
|
|
(6.8) % |
|
|
(0.7) % |
|
|
(13.3) % |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230808992087/en/
Media:
Wag!: Media@wagwalking.com
Investor Relations:
Wag!: IR@wagwalking.com
ICR for Wag!: WagIR@icrinc.com
Source: